🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

2025 Common Sense Oncology Common Sense Oncology Leadership Meeting: Global Voices, Bold Vision — an inspiring launch to the CSO Annual Leadership Meeting, bringing together global leaders in cancer care, research, and advocacy. Happening now—don’t miss it!

Great discussion here: Cancer research Fund, Global oncology Funding, Countries healthcare priorities and How to leverage Domestic Health Funding Common Sense Oncology

CT could be responsible for approximately 5% of cancers diagnosed each year. This would place CT on par with other significant risk factors, such as alcohol consumption (5.4%) and excess body weight (7.6%). jamanetwork.com/journals/jamai…

My Substack blog is back!. #subscribe and #share The Role of Mentorship for Young African Health Researchers, by Omar Abdihamid Substack open.substack.com/pub/omaryhamid…

Happy to share that two Common Sense Oncology projects have been accepted for poster presentation at #ASCO25 Looking forward to discussing our findings 😊

Nonoperative Management of Mismatch Repair–Deficient Tumors Stage 1-3, 6-mo dostarlimab cCR All ➡️ 84 pts (82%) Rectal➡️💯% Other➡️65% Almost all patients with CCR did not undergo surgery 2y RFS➡️92% 💥ctDNA correlated with response #AACR25 nejm.org/doi/full/10.10…

3 IO trials in non-metastatic #HeadNeckCancer: ✅ KEYNOTE-689 (positive!) ❌ JAVELIN Head Neck 100 ❌ KEYNOTE-412 Why did keynote 689 succeed? ➡️ IO before and after surgery (perioperative) ➡️ Smarter tumor debulking ➔ better IO effect! Next at #ASCO25: NIVO post-op trial!

Thanks Sam. Was lovely seeing you in Montreal . All the best in your fellowship

Looking forward to the course as an avid sensible medicine student

Worth a discussion really which we always shy away from. I would argue risk-stratified and disease specific surveillance is fair

Just published: our editorial on Strategies to improve cancer care and research in Africa. #advocacy remains the best tool AORTIC AFREhealth Official

Destiny-Breast-09 will likely establish a new first-line therapy for HER2+ MBC. Here are my considerations going into #ASCO25 Patient population considerations: 1) De novo patients (capped at 50%): these patients are more likely to respond durably and possibly even be cured in

🧵1/ 🚨 Thrilled to announce the simultaneous publication of our fellowship project during #ASCO25 in #Chicago! We analyzed 50 phase 3 cancer trials published in top journals in 2023. 👇 What we found was eye-opening. #CommonSenseOncology

2/Title: Adherence of Published Randomized Phase 3 Cancer Trials to CSO Principles Key results – Only 50% of trials justified their control arms – Just 36% justified the primary endpoint – 14% included quality-of-life as an outcome – Only 2 trials addressed long-term toxicities

3/ Only 3 trials mentioned drug costs. These gaps show why we need trial designs that truly prioritize what matters to patients. CSO’s checklist offers a path to better: – Transparency – Practical endpoints – Affordability – Patient-reported outcomes #valuebasedcare

5/ ✅ We call for stronger adherence to #CSO principles across oncology trials. Let’s align cancer research with real-world value and patient-centered care. 📚 Full abstract: ascopubs.org/doi/10.1200/JC… Bishal Gyawali, MD, PhD, FASCO Fumiko Ladd Chino, MD, FASCO #GlobalOncology #ClinicalTrials #ASCO25

Happy Eidd to all brothers and sisters in Islam . I wrote about the parallel story of sacrifice of Eid-al Adha and cancer world. Subscribe to my Substack open.substack.com/pub/omaryhamid…

Join us on 19tj june as we break down some of the top studies presented at ASCO 2025. KESHO AORTIC

Men’s health awareness month with a theme of men’s cancer care needs amid all the heavy lifting that society expects from men. Read my substack article and subscribe: open.substack.com/pub/omaryhamid…

Wrote a substack article on refugees and their neglected cancer care in east Africa . Please subscribe below and share open.substack.com/pub/omaryhamid… IOM - UN Migration 🇺🇳 IOM Kenya Mohammed A. Waranle, PhD (c) Mohamed Wehliye, MBS